B2Gold cites Fekola impairment reversal as Q3 earnings driver
B2Gold management attributed its Q3 2026 earnings rise to a reversal of the Fekola impairment.
B2Gold management attributed its Q3 2026 earnings rise to a reversal of the Fekola impairment.